More reads

• Depression drug related to ketamine wins endorsement of key advisory panel. (STAT)
• FDA 'breakthrough' designations have little effect on biotech stock prices. (Nature Reviews Drug Discovery)
• Our year in review: annual talk on macro, biotech, and Atlas. (LifeSciVC)
• Longevity scientists launch academy to raise profile of life-extending research. (STAT Plus)